Clinical Trial Update: Study of Cimzia for the Treatment of Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for Cimzia in ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• CIMZIA (CERTOLIZUMAB PEGOL)

Snippet

Sponsor: University of Washington | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED